Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Never charge Batteries inside of the model
Injection-Based Administration Subcutaneous injections: All GLP-1 RAs are administered via subcutaneous injection Prefilled pens: Most common delivery system, allows for self-administration Auto-injectors: Simplify the process for patients with dexterity issues Multi-dose pens: Require dose dialing and needle attachment Dosing frequency: Daily: Liraglutide (Saxenda, Victoza), some formulations of exenatide (Byetta) Weekly: Semaglutide (Wegovy, Ozempic), tirzepatide (Mounjaro, Zepbound), dulaglutide (Trulicity), exenatide extended-release (Bydureon) Titration schedules: Most FDA-approved GLP-1 RAs require gradual dose escalation to minimize gastrointestinal side effects
Frustrated by chronic joint pain, muscle tears, or a slow, painful post-surgical recovery
Ahmed AE et al
To further clarify the role of the Lys8 residue in the function of OsDHAR, we examined the effects of substitution of Lys to Ala at this position
US$ 27.24
US$ 20.25
US$ 28.04
